De Backer Marianne
SEC CIK 1797819 · EDGAR
BoughtSold
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 17:43 | 2026-04-29 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | Pres, CEO, Dir | J - Other | $0.00 | -233.5K | 714.6K | -25% | $0 | |
| I | 2026-04-30 17:43 | 2026-04-29 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | Pres, CEO, Dir | J - Other | $0.00 | +233.5K | 286.6K | +440% | $0 |
| T | 2026-04-07 16:50 | 2026-04-06 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | Pres, CEO, Dir | S - Sale | $9.16 | -72.6K | 948.1K | -7% | -$664.4K |
| 2026-02-26 | 2026-02-24 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | S - Sale | $9.53 | -14.8K | 1.02M | -1% | -$140.7K | |
| D | 2026-02-24 | 2026-02-22 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | A - Grant | $0.00 | +285.0K | 1.05M | +37% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | S - Sale | $7.45 | -19.0K | 1.04M | -2% | -$141.8K |
| 2025-04-04 | 2025-04-03 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | S - Sale | $5.95 | -79.7K | 769.5K | -9% | -$474.3K | |
| D | 2025-02-25 | 2025-02-24 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | S - Sale | $9.45 | -16.1K | 849.2K | -2% | -$152.4K |
| D | 2025-02-25 | 2025-02-22 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | A - Grant | $0.00 | +240.0K | 865.3K | +38% | $0 |
| 2024-06-12 | 2024-06-12 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | J - Other | $0.00 | -53.1K | 625.3K | -8% | $0 | |
| I | 2024-06-12 | 2024-06-12 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | J - Other | $0.00 | +53.1K | 53.1K | New | $0 |
| 2024-04-04 | 2024-04-03 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | S - Sale | $9.46 | -73.0K | 678.5K | -10% | -$690.5K | |
| D | 2024-02-26 | 2024-02-22 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO, Dir | A - Grant | $0.00 | +175.0K | 751.5K | +30% | $0 |
| D | 2023-04-04 | 2023-04-03 | VIR | Vir Biotechnology, Inc. | De Backer Marianne | CEO | A - Grant | $0.00 | +576.5K | 576.5K | New | $0 |
| D | 2023-01-11 | 2023-01-10 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | De Backer Marianne | Dir | A - Grant | $0.00 | +7,867 | 31.3K | +34% | $0 |
| 2022-01-07 | 2022-01-07 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | De Backer Marianne | Dir | A - Grant | $0.00 | +6,400 | 23.4K | +38% | $0 | |
| M | 2022-01-04 | 2022-01-03 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | De Backer Marianne | Dir | S - Sale | $64.71 | -4,500 | 17.0K | -21% | -$291.2K |
Purchase Sale Sale after option exercise All abbreviations